Anti program death-1/anti program death-ligand 1 in digestive cancers

doi:10.4251/wjgo.v7.i8.95

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10326)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

720

WORD

406

HTML

4456

Figures (1-3)

159

Tables (1-1)

150

Sum=5891

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

552

Download

1583

Sum=2135

Publishing Process of This Article

Item

Count

Browse

1074

Download

1226

Sum=2300

Aug 15, 2015 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (41)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Aug 15, 2015; 7(8): 95-101
Published online Aug 15, 2015. doi: 10.4251/wjgo.v7.i8.95

Full Size Figure Download Figure

Figure 3 MODUL Phase III trial design. 5FU: 5-Fluoro-Uracil; LV: Leucovorin; SD: Stable disease; R: Randomization; PD: Progressive disease.

Citation: Guillebon E, Roussille P, Frouin E, Tougeron D. Anti program death-1/anti program death-ligand 1 in digestive cancers. World J Gastrointest Oncol 2015; 7(8): 95-101
URL: https://www.wjgnet.com/1948-5204/full/v7/i8/95.htm
DOI: https://dx.doi.org/10.4251/wjgo.v7.i8.95